Cogent Biosciences, Inc.·4

Jul 5, 4:53 PM ET

Ros Matthew 4

4 · Cogent Biosciences, Inc. · Filed Jul 5, 2023

Insider Transaction Report

Form 4
Period: 2023-07-03
Ros Matthew
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-07-03+1,7431,743 total
    Exercise: $11.96From: 2023-07-03Exp: 2033-07-03Common Stock (1,743 underlying)
Footnotes (1)
  • [F1]The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4